Related Patent News
Competitive Technologies Announces Notice Of Allowance For Second Patent
Fairfield, CT. - Competitive Technologies, Inc (AMEX: CTT) today announced that the U.S. Patent Office has issued a Notice of Allowance for the U.S. Divisional Patent Application for CTT’s nanotechnology bone biomaterial developed at the University of South Carolina (“USC”). As a result, CTT expects that a second patent will be issued relating to this technology sometime this summer. CTT has an exclusive agreement with the University of South Carolina Research Foundation to license and commercialize this injectable, calcium phosphate-based biomaterial nanotechnology. The inventor of the bone biomaterial, Dr. Brian R. Genge, is a research professor in the Department of Chemistry and Biochemistry at USC. “The granting of this second patent recognizes the unique qualities of Dr. Genge’s innovative nanoparticle biomaterial technology,” said Dr. Mike Kiley, CTT’s Executive Vice President and Chief Technology Officer. “CTT executed an exclusive license in September 2005 with Soteira Inc.
Call Our Toll Free: (888) 275-2757 or Contact Us
Online For a No-Obligation Consultation
Bookmark: 
Permalink: http://S-0.ORG/tDMtZwC
| Did You Know? |
|
There is a time limit on patent protection.
For applications filed on or after June 8, 1995, utility and plant patents are granted for a term which begins with the date of the grant and usually ends 20 years from the date you first applied for the patent subject to the payment of appropriate maintenance fees. Design patents last 14 years from the date you are granted the patent. Note: Patents in force on June 8 and patents issued thereafter on applications filed prior to June 8, 1995 automatically have a term that is the greater of the twenty year term discussed above or seventeen years from the patent grant.
|
Contact our Patent Professionals to ensure you complete the
patent filing process correctly or for violation of your patent rights.
|